Factors predisposing to the development of progressive massive fibrosis in coal miners.

Silicosis and coal workers' pneumoconiosis. Environ Health Perspect (2000) 1.83

Progressive massive fibrosis and simple pneumoconiosis in ex-miners. Br J Ind Med (1985) 1.28

Exposure to respirable coalmine dust and incidence of progressive massive fibrosis. Br J Ind Med (1987) 1.00

Update on lung disease in coalminers. Br J Ind Med (1987) 0.96

Prevalence and pathogenesis of pneumoconiosis in coal workers. Environ Health Perspect (1988) 0.81

Factors associated with the development of progressive massive fibrosis in British coalminers: a case-control study. Br J Ind Med (1989) 0.80

British data on coal miners' pneumoconiosis and relevance to US conditions. Am J Public Health (1992) 0.77

Quantitative relations between exposure to respirable coalmine dust and coalworkers' simple pneumoconiosis in men who have worked as miners but have left the coal industry. Br J Ind Med (1986) 0.75

An epidemiological study of rheumatoid arthritis associated with characteristic chest x-ray appearances in coal-workers. Br Med J (1953) 10.93

Pneumoconiosis and respiratory symptoms in miners at eight collieries. Br Med J (1961) 5.20

Relation between radiographic categories of coalworkers' pneumoconiosis and expectation of life. Br Med J (1973) 3.05

The attack rate of progressive massive fibrosis. Br J Ind Med (1962) 2.91

THE MORTALITY OF MINERS AND EX-MINERS IN THE RHONDDA FACH. Br J Ind Med (1964) 2.09

Factors influencing the radiological progression rate of progressive massive fibrosis. Br J Ind Med (1956) 1.79

The relationship between coal rank and the prevalence of pneumoconiosis. Br J Ind Med (1979) 1.60

The radiographic progression of progressive massive fibrosis. Tubercle (1961) 1.49

Circulating antinuclear antibody and rheumatoid factor in coal pneumoconiosis. Br Med J (1974) 1.39

Influence of the Society of Apothecaries upon medical education. Br Med J (1956) 0.99

The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84

Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 15.54

The UCSC genome browser database: update 2007. Nucleic Acids Res (2006) 13.04

The UCSC Genome Browser Database: update 2006. Nucleic Acids Res (2006) 11.05

NF-AT components define a family of transcription factors targeted in T-cell activation. Nature (1994) 4.90

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02

Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol (2000) 3.46

The management of diabetes during surgery. Br J Anaesth (1979) 2.20

Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study. Eur J Vasc Endovasc Surg (2005) 2.19

Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol (2001) 2.03

Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. Methods of scoring and classification, with implications for left ventricular assist device utilization. J Thorac Cardiovasc Surg (1977) 1.96

The folding and stability of titin immunoglobulin-like modules, with implications for the mechanism of elasticity. Biophys J (1995) 1.93

NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J Biol Chem (1995) 1.91

Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol (2001) 1.84

Effect of haematocrit on cerebral blood-flow in man. Lancet (1977) 1.80

Cerebral blood-flow in polycythaemia. Lancet (1977) 1.79

Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem Biol Interact (1994) 1.77

Quartz and pneumoconiosis in coalminers. Lancet (1981) 1.75

Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease. Ann Rheum Dis (1983) 1.64

Nervous system involvement in ankylosing spondylitis. Br Med J (1974) 1.62

Clinical NMR imaging of the brain: 140 cases. AJR Am J Roentgenol (1982) 1.61

The relationship between coal rank and the prevalence of pneumoconiosis. Br J Ind Med (1979) 1.60

Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrob Agents Chemother (1989) 1.59

Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect (1999) 1.56

Arctic marine ecosystem contamination. Sci Total Environ (1992) 1.44

Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem Res Toxicol (1997) 1.43

Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum (1995) 1.43

Piezo-ceramic lithotripsy of gallbladder stones: initial experience in 38 patients. Lancet (1988) 1.40

Compartment syndrome and intraaortic balloon. Thorac Cardiovasc Surg (1986) 1.40

Brain CT infarction in patients with carotid atheroma. Does it predict a future event? Int Angiol (2001) 1.39

Periodic hypothermia. Br Med J (1973) 1.39

Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation (1995) 1.39

Relative safety of intravenous digital subtraction angiography over other methods of carotid angiography and impact on clinical management of cerebrovascular disease. Br J Radiol (1989) 1.33

Biomechanics of skull fracture. J Neurotrauma (1995) 1.33

Haemodialysis and cerebral oedema. Nephron (2001) 1.33

Irregularly shaped small shadows on chest radiographs, dust exposure, and lung function in coalworkers' pneumoconiosis. Br J Ind Med (1988) 1.32

Obesity and hypertension in a longitudinal study of black physicians: the Meharry Cohort Study. J Chronic Dis (1986) 1.30

Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med (1997) 1.30

Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol (2001) 1.30

Continuous lumbar epidural analgesia using bupivicaine: a study of the fetus and newborn child. J Obstet Gynaecol Br Commonw (1971) 1.29

Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem (1983) 1.28

Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem Res Toxicol (1999) 1.26

Report of laparoscopic cholecystectomy in two patients with left-sided gallbladders. JSLS (2001) 1.26

Whole blood viscosity and cerebral blood flow. Stroke (1982) 1.24

NMR imaging of the brain using spin-echo sequences. Clin Radiol (1982) 1.24

Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem Res Toxicol (1999) 1.22

An intravenous 133xenon clearance technique for measuring cerebral blood flow. J Neurol Sci (1979) 1.22

Preservation of autoregulation of cerebral blood flow in autonomic failure. J Neurol Sci (1980) 1.22

Presence and implications of chemical contaminants in the freshwaters of the Canadian Arctic. Sci Total Environ (1992) 1.17

Transfer of arsenite from glutathione to dithiols: a model of interaction. Chem Res Toxicol (1994) 1.15

Risk factors and the incidence of hypertension in black physicians: the Meharry Cohort Study. Am Heart J (1985) 1.14

Clinical NMR imaging of the brain in children: normal and neurologic disease. AJR Am J Roentgenol (1983) 1.12

Precursors of hypertension in black medical students: the Meharry cohort study. J Natl Med Assoc (1984) 1.12

Metabolic effects of salbutamol infusion during premature labour. Br J Obstet Gynaecol (1977) 1.10

Kleine-Levin syndrome: report of two cases with onset of symptoms precipitated by head trauma. Br J Psychiatry (1988) 1.10

Cerebral haemodynamic changes after extracranial-intracranial bypass surgery. J Neurol Neurosurg Psychiatry (1987) 1.09

Comparative in vitro methylation of trivalent and pentavalent arsenicals. Toxicol Appl Pharmacol (1995) 1.09

Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem Biol Interact (1996) 1.05

Strut fracture with Björk-Shiley 70 degrees convexo-concave valve. An international multi-institutional follow-up study. Eur J Cardiothorac Surg (1992) 1.04

Complexation of arsenic species in rabbit erythrocytes. Chem Res Toxicol (1995) 1.04

Hyperglycaemic effects of Hartmann's solution during surgery in patients with maturity onset diabetes. Br J Anaesth (1978) 1.04

Comparison of angiographic and CT findings between patients with multi-infarct dementia and those with dementia due to primary neuronal degeneration. Neuroradiology (1978) 1.04

Binding of arsenicals to proteins in an in vitro methylation system. Toxicol Appl Pharmacol (1997) 1.03

Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet (1984) 1.03

Variations in mean cerebral blood flow under anesthesia at rest and during cortical activation. Stroke (1977) 1.03

Letter: Renal carcinoma and coffee consumption in 16 countries. Br J Cancer (1973) 1.02

Cardiovascular disease in African American and white physicians: the Meharry Cohort and Meharry-Hopkins Cohort Studies. J Health Care Poor Underserved (1997) 1.02

Assessment of cerebral haemodynamic reserve: correlation between PET parameters and CO2 reactivity measured by the intravenous 133 xenon injection technique. J Neurol Neurosurg Psychiatry (1988) 1.01

Evaluation and treatment of anterior knee pain using eccentric exercise. Med Sci Sports Exerc (1986) 1.00

Nuclear magnetic resonance imaging of the posterior fossa: 50 cases. Clin Radiol (1983) 1.00

Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J (1996) 1.00

Effect of high haematocrit on alertness. Lancet (1980) 0.99

Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int (1989) 0.99

Detection of somatic muscle fasciculation on electrocardiograms. Br Med J (1976) 0.98

Isolation of Trichomonas vaginalis resistant to metronidazole. Lancet (1981) 0.96

Case report: ureteric obstruction secondary to contralateral hydronephrosis. Br J Radiol (1994) 0.96

Myasthenia gravis presenting with stridor. Thorax (1996) 0.96

Salbutamol-induced diabetic ketoacidosis. Br Med J (1977) 0.94

The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacin. J Antimicrob Chemother (1988) 0.94

The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study. Aims and results of quality control. Int Angiol (2003) 0.93

Longitudinal study of intracellular T cell cytokine production in infants compared to adults. Clin Exp Immunol (2002) 0.93

In vitro methylation of inorganic arsenic in mouse intestinal cecum. Toxicol Appl Pharmacol (1997) 0.92

Prostacyclin administration during cardiopulmonary bypass in man. Lancet (1981) 0.92

In vitro inhibition of glutathione reductase by arsenotriglutathione. Biochem Pharmacol (1995) 0.92

Multi-infarct dementia. J Neurol Sci (1979) 0.92

Prostaglandin E2 compared with oxytocin for the induction of labour. Br Med J (1971) 0.91

Liberation and analysis of protein-bound arsenicals. J Chromatogr B Biomed Appl (1996) 0.91

Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology (2003) 0.90

Coronary artery spasm during mitral valve replacement. Eur J Cardiothorac Surg (1990) 0.90

Quantitative analysis of one-dimensional gel electrophoresis profiles. Comput Appl Biosci (1990) 0.90

Precursors of hypertension in black compared to white medical students. J Chronic Dis (1987) 0.90

Pseudo-Meigs' syndrome masquerading as tuberculous effusion. Tubercle (1972) 0.90